HRT Financial’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
SCM
QCM
HRT Financial's NVCR Position: Q2 2026 in Review
HRT Financial opened a new position in NovoCure (NVCR) in Q2 2026: 392,319 shares worth $5.94M. The stake represents 0.01% of the portfolio and ranks #1061 among its holdings. This is a return to the name: HRT Financial previously reported a position in NVCR as recently as Q4 2025.
HRT Financial first reported a position in NVCR in Q3 2019 and has held it in 14 quarters since. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.
- HRT Financial held 392,319 shares of NovoCure worth $5.94M as of Q2 2026.
- NovoCure was a new HRT Financial position in Q2 2026.
- NovoCure made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1061 holding.
- HRT Financial first reported a position in NovoCure in Q3 2019 and has held it in 14 quarters since.
- 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.
Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.